# CYTARABINE
> **ANDA208485** · Abbreviated New Drug Application (Generic) · Sponsor: MEITHEAL · Approved 2022-02-28
## Drug
- **FDA Application Number:** ANDA208485
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CYTARABINE
- **Generic name:** CYTARABINE
- **Active ingredients:** CYTARABINE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** MEITHEAL
- **Manufacturer:** Meitheal Pharmaceuticals Inc.
- **First approval:** 2022-02-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208485)
---
*MORVS · CC0 1.0*